The Screenings You Actually Need at Your Age

How we separated the screenings that save lives from the ones that just feel thorough

We worked from the U.S. Preventive Services Task Force evidence database — the most rigorous independent review of preventive care in existence — and cross-referenced it with Cochrane systematic reviews and the peer-reviewed literature on overdiagnosis in older adults. We did not start from the assumption that more testing is better. We asked: for each screening, does it actually reduce mortality or serious morbidity in people over 50, 60, or 70? The answer varies significantly by test, by age, and by individual risk profile — which is exactly why a single "annual physical checklist" approach fails so many people.

• ✓
  USPSTF Grade A & B recommendations reviewed Confirmed which screenings have strong or moderate evidence of benefit and a favourable harm-to-benefit ratio for adults 50–80, stratified by sex and age decade.
• ✓
  Cochrane Reviews on screening harms consulted Confirmed that several popular tests — including annual ECGs, full-body CT scans, and routine PSA testing in men over 70 — produce net harm through overdiagnosis and unnecessary treatment in older adults.
• ✓
  Upper age limits for screening examined Confirmed that evidence for benefit weakens or disappears beyond certain ages for some screenings (e.g. colorectal cancer screening past 75–85 offers diminishing returns and the USPSTF recommends against it past 85), meaning stopping is sometimes the right clinical decision.
• ✓
  Overdiagnosis literature in seniors reviewed Confirmed that incidental findings from low-value screening in older adults lead to a cascade of follow-up procedures, with documented harms including unnecessary surgery, anxiety, and significant out-of-pocket cost — without reducing mortality.

There's no single right list — here's how to build yours

Your ideal screening schedule depends on your age, sex, personal and family health history, and whether you've already completed certain one-time tests. Here are the four practical approaches, from most to least involved.

What sounds thorough but isn't

Several approaches to health screening are popular, feel reassuring, and are aggressively marketed — but the evidence does not support them, and some cause measurable harm. Here's what to avoid.

• ✗
  Full-body CT or MRI "executive health" scans — These are not recommended by any major evidence-based medical body for average-risk adults. They reliably produce incidental findings — spots and nodules that are almost always harmless — which then trigger a cascade of biopsies, additional imaging, and procedures that carry real risks, including radiation exposure from follow-up CTs, surgical complications, and significant anxiety. The scans themselves can cost $1,000–$5,000 and are not covered by insurance precisely because the evidence of benefit doesn't exist.
• ✗
  Annual EKGs or cardiac stress tests in people without symptoms — The USPSTF explicitly recommends against routine resting EKG screening for cardiovascular risk prediction in low-risk adults. In people without symptoms or known heart disease, routine EKGs do not reduce cardiac events and the abnormal readings they generate lead to unnecessary specialist referrals and interventional procedures. If you have symptoms — chest pain, palpitations, unexplained shortness of breath — that's a different matter entirely.
• ✗
  Continuing screenings past the age where evidence supports them — Mammography past 74, PSA testing past 70 in men without elevated risk, and colonoscopy past 85 are all situations where the burdens — procedural risk, overdiagnosis, treatment of slow-growing cancers in people with limited life expectancy — outweigh the benefits. The right move is not always to keep doing what you've always done; stopping a screening at the right time is a medical decision, not negligence.
• ✗
  Comprehensive "longevity panels" from direct-to-consumer labs — These are marketed as proactive health intelligence but frequently include dozens of markers with no established clinical utility — or with reference ranges not validated for older adults. When they flag an "abnormality," your primary care doctor may feel obligated to investigate it even when the finding has no meaningful predictive value. Stick to tests ordered with a specific clinical question in mind.